U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07216482) titled 'A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)' on Oct. 10.
Brief Summary: Researchers designed a study medicine called enlicitide to lower low-density lipoprotein cholesterol (LDL-C). In this study, researchers want to learn about giving enlicitide with another medicine called rosuvastatin. Rosuvastatin is a standard (usual) treatment to lower LDL-C.
The goal of this study is to learn if enlicitide given with rosuvastatin works better than placebo on lowering LDL-C in a person's blood. A placebo looks like the study medicine but has no study medicine in it. Using a placebo helps researchers bett...